Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer.
about
Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCCSalivary Genomics, Transcriptomics and Proteomics: The Emerging Concept of the Oral Ecosystem and their Use in the Early Diagnosis of Cancer and other Diseases.High-risk human papillomavirus (HPV) screening and detection in healthy patient saliva samples: a pilot study.HPV-associated head and neck cancer: a virus-related cancer epidemic.Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy.Screening and detection of human papillomavirus (HPV) high-risk strains HPV16 and HPV18 in saliva samples from subjects under 18 years old in Nevada: a pilot studyIdentification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma.The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview.Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer.Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomasThe role of sexual behavior in head and neck cancer: implications for prevention and therapy.Application of the hybrid capture 2 assay to squamous cell carcinomas of the head and neck: a convenient liquid-phase approach for the reliable determination of human papillomavirus status.Current trends in the etiology and diagnosis of HPV-related head and neck cancers.A review on salivary genomics and proteomics biomarkers in oral cancer.Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma.Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance.Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer.A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patientsDetection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.Human Papillomavirus Laboratory Testing: the Changing ParadigmPoint-of-care diagnostics enter the mouth.Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative studyAbsence of high-risk HPV 16 and 18 in Chinese patients with oral squamous cell carcinoma and oral potentially malignant disordersEDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions.Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatmentHuman papilloma virus prevalence in a multiethnic screening populationHPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumoursEpidemiology of oral human papillomavirus infection.Cytomorphologic diagnosis and HPV testing of metastatic and primary oropharyngeal squamous cell carcinomas: a review and summary of the literature.The expanding role of cytopathology in the diagnosis of HPV-related squamous cell carcinoma of the head and neck.Saliva testing for human papilloma virus in oropharyngeal squamous cell carcinoma: A diagnostic accuracy study.Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.Ultrasensitive detection of oncogenic human papillomavirus in oropharyngeal tissue swabsA comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option.Markers of HPV infection and survival in patients with head and neck tumors.Human papillomavirus associated head and neck squamous cell carcinoma: Controversies and new concepts.Detection of HPV related oropharyngeal cancer in oral rinse specimens.HPV-negative, but not HPV-positive, oropharyngeal carcinomas induce fibroblasts to support tumour invasion through micro-environmental release of HGF and IL-6.Prevalence of oral HPV infection among healthy individuals and head and neck cancer cases in the French West Indies.Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.
P2860
Q21561014-74CCCF8C-391A-4B56-BD6E-49182D00BD48Q30489779-F36CCE4B-08AE-4746-94A7-433C782A3B38Q34045061-12C94294-4882-4D6E-892B-D368A7187F56Q34114152-F28117E6-CFFB-4EE4-A9C5-ECA0F33A1EECQ34153823-BE2FFCCF-D2B7-45C4-9C21-8C1DF5796B53Q34454168-48FC3FD3-5711-4A9C-8B1C-930A3986CCC2Q34590776-EBEDA280-FCFA-49C4-A476-4341E5F4E21DQ34769922-3BE2A995-F192-4019-B236-07A3B1A020B6Q35038194-B48EFDB8-E5F8-4041-9444-8DC3786B1470Q35052911-40F8CA47-100E-4BA7-814B-DD2C844336ACQ35272050-521B9A36-7000-400D-9285-88125E66EF01Q35403352-A3ABC3A4-7DE8-4838-93B6-C8890A53ECA5Q35469459-4945D114-392D-4AEB-BEA6-4158E9DD6641Q35533908-779918C8-81D3-4597-99AE-291F078B0AF3Q35547426-6E8574E4-8DC0-4B60-A341-D2EF7D984B61Q35547513-8B84B3DA-DEFE-4CA4-81CC-473978C0A8DFQ35784536-DCE5C541-9480-4DC1-9D60-E8C87D069279Q35945485-5DC059C9-C82C-472E-ACEE-363765ABB014Q36405912-32E7671D-3B78-4862-B899-851217DA6774Q36675236-C36DBA2D-28F6-4A95-B614-A1115AB49F51Q36736982-9719C8C5-5824-4EB9-8FF8-61A7DD13B417Q36812119-925D7F65-5D9F-4CEB-A21F-286D6CCA3416Q36923432-7980CAFB-A5F1-4321-A663-457FC42EDF11Q36941462-72BD748C-11DF-4B6D-802B-ACEDF077A22AQ36988805-2E3F2046-6D21-4EC0-BB1E-3D8601B0FDF1Q37000170-AF8C6D20-9A3A-4C3C-A2E6-4251222D209FQ37566987-B4BF1080-71DD-4054-9A97-A00CC197DAFBQ37669732-5489DB79-F158-477C-92B2-707FF4535389Q37986696-91B55471-931C-4AF4-87CA-D7D350394B0CQ38113193-328F2CB1-2C23-46FC-B35E-DF7C81C2278CQ40157573-07F33B2D-9890-4654-BBF7-123661208017Q40360475-C0B5EC28-B48E-48E2-9C1F-56624AF7A19EQ40435439-33E061D3-3315-452B-89DA-9508C4380A5BQ41658087-EE284AC3-6385-49EB-B207-4CC0605D10E6Q46584014-0DDB3424-31CB-4959-8ED5-F169EDB40D47Q47095041-1D055E11-0B93-4DFA-93AA-1B65F84CC0E5Q47170335-DC16B621-0D9C-43D8-A733-EC95DC024FEEQ47593658-405EB957-DAEB-4149-B9DE-9BC668F67CC5Q47921908-81C1299D-0E9F-429A-9CE4-81D208E027D1Q50065081-DC6AB428-88E5-4934-8F16-FB80F97D4B4B
P2860
Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Feasibility of quantitative PC ...... HPV for head and neck cancer.
@en
Feasibility of quantitative PC ...... HPV for head and neck cancer.
@nl
type
label
Feasibility of quantitative PC ...... HPV for head and neck cancer.
@en
Feasibility of quantitative PC ...... HPV for head and neck cancer.
@nl
prefLabel
Feasibility of quantitative PC ...... HPV for head and neck cancer.
@en
Feasibility of quantitative PC ...... HPV for head and neck cancer.
@nl
P2093
P356
P1476
Feasibility of quantitative PC ...... HPV for head and neck cancer.
@en
P2093
David Sidransky
Eli Rosenbaum
Joseph Califano
Wayne Koch
Weiwen Jiang
P2860
P304
P356
10.1002/IJC.21216
P577
2005-11-01T00:00:00Z